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Summary 23 
Coagulase-negative staphylococci (CNS) are the predominant cause of bovine intra-24 
mammary infections. They can lead to chronic infections and were reported to significantly 25 
increase milk somatic cell counts. The goal of our study was to determine the species 26 
distribution and antimicrobial susceptibility profiles of CNS in bovine mastitis milk samples 27 
in Switzerland. Between March 2011 and February 2012, a total of 120 CNS were isolated 28 
from mastitis milk samples from 117 different animals at 77 farms. The isolates were 29 
identified by matrix-assisted laser desorption ionization - time of flight mass spectrometry 30 
(MALDI-TOF MS) and subsequently tested for sensitivity to various antibiotic agents by 31 
disk diffusion. Antimicrobial agents were selected mainly based on their relevance to the 32 
treatment of bovine mastitis in Switzerland. MALDI-TOF MS assigned the 120 isolates to 33 
12 different staphylococcal species - S. chromogenes (33%), S. xylosus (28%), S. sciuri 34 
(13%), S. haemolyticus (9%), S. epidermidis (4%), S. simulans (4%), S. warneri (3%), S. 35 
equorum (2%), S. hyicus (2%), S. cohnii (1%), S. succinus (1%), and S. fleuretti (1%). 36 
Resistance rates in CNS were high, with 39% of isolates exhibiting resistance to ampicillin 37 
and penicillin, 6% of isolates being resistant to amoxicillin with clavulanic acid, ceftiofur, 38 
cephalothin, and cefoxitin, and 5% being resistant to erythromycin. In rare cases resistance 39 
to gentamicin (2%), kanamycin (2%), and kanamycin-cefalexin (1%) was detected. 40 
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Speziesverteilung und Resistenzprofile Koagulase-negativer Staphylokokken isoliert 46 
von Rindern mit Mastitis in der Schweiz 47 
 48 
Koagulase-negative Staphylokokken (CNS) stellen die häufigste Ursache intramammärer 49 
Infektionen beim Rind dar. Sie können chronische Infektionen verursachen und den 50 
somatischen Zellgehalt der Milch deutlich erhöhen. Ziel dieser Studie war es, die 51 
Speziesverteilung und Resistenzprofile von CNS in bovinen Mastitismilchproben zu 52 
bestimmen. Zwischen März 2011 und Februar 2012 wurden 120 CNS aus 53 
Mastitismilchproben von 117 verschiedenen Kühen auf 77 landwirtschaftlichen Betrieben 54 
isoliert. Die Isolate wurden mittels MALDI-TOF MS (matrix-assisted laser desorption 55 
ionization - time of flight mass spectrometry) Technologie identifiziert und anschließend 56 
mittels Agardiffusion auf ihre Empfindlichkeit gegenüber diverser Antibiotika getestet. Die 57 
getesteten Antibiotika wurden vor allem anhand ihrer Relevanz in Bezug auf die 58 
Behandlung boviner Mastitiden in der Schweiz ausgewählt. MALDI-TOF MS ordnete die 59 
120 Isolate 12 verschiedenen Staphylokokken Spezies zu - S. chromogenes (33%), S. 60 
xylosus (28%), S. sciuri (13%), S. haemolyticus (9%), S. epidermidis (4%), S. simulans 61 
(4%), S. warneri (3%), S. equorum (2%), S. hyicus (2%), S. cohnii (1%), S. succinus (1%) 62 
und S. fleuretti (1%). Insgesamt betrachtet lag der Anteil resistenter CNS hoch, wobei 39% 63 
der Isolate als resistent gegen Ampicillin und Penicillin, 6% als resistent gegen Amoxicillin 64 
mit Clavulansäure, Ceftiofur, Cephalothin und Cefoxitin und 5% als resistent gegen 65 
Erythromycin eingestuft wurden. In seltenen Fällen wurden auch Resistenzen gegen 66 
Gentamicin (2%), Kanamycin (2%) und Kanamycin-Cefalexin (1%) gefunden. 67 
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Introduction 72 
 73 
Mastitis remains a major challenge to the worldwide dairy industry. While coagulase-74 
negative staphylococci (CNS) are often referred to as „minor pathogens“ limited to 75 
subclinical or mild cases of mastitis, their clinical relevance is controversially discussed ( 76 
Supré et al., 2011; De Vliegher et al., 2012). CNS are the most common bacteria associated 77 
with bovine intramammary infections (IMI) (Makovec and Ruegg, 2003; Tenhagen et al., 78 
2006; Schukken et al., 2009). They can cause chronic infections (Gillespie et al. 2009), 79 
exhibit virulence factors such as cytotoxins (Allaker et al., 1991; Zhang and Maddox, 2000; 80 
Taponen and Pyörälä, 2009), and were shown to represent a risk factor for acquiring 81 
Staphylococcus (S). aureus intramammary infections (Reyher et al., 2012) . 82 
Regarding the effect of CNS IMI on milk production, different studies yield conflicting 83 
results. While some reported decreased milk production (Green et al., 2006), others 84 
observed a slight but significant increase in milk production in cows with CNS IMI 85 
compared to culture-negative cows (Gillespie et al., 2009; Schukken et al., 2009).  86 
CNS were shown to increase milk somatic cell counts (SCC) in individual cows and can 87 
contribute significantly to bulk milk SCC on herd level, espcecially in herds with a bulk 88 
milk SCC below 200'000 cells/mL (Schukken et al., 2009). The effect of CNS on SCC 89 
differs between species (Supré et al., 2011), stressing the need to gain more information on 90 
the distribution of different CNS. However, the prevalence of CNS isolated from bovine 91 
milk varies greatly in different geographical locations (Gillespie et al., 2009; Piessens et al., 92 
2011; Waller et al., 2011; Pate et al., 2012) and to date, there is no data on the prevalence 93 
and species distribution of CNS in Switzerland. As CNS tend to be more resistant to 94 
antimicrobial agents than S. aureus and develop multiresistance easily (Taponen and 95 
Pyörälä, 2009), close surveillance of antimicrobial resistance is necessary to ensure the 96 
reasonable use of antibiotic agents and to control the development and spread of resistant 97 
strains. Therefore, the goal of our study was to determine the species distribution and 98 
antimicrobial susceptibility of CNS in bovine milk samples in Switzerland. 99 
 100 
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Material and Methods 101 
Bacterial Isolates 102 
A total of 120 coagulase-negative staphylococci (CNS) from clinical and subclinical cases 103 
of bovine mastitis were isolated from 117 different animals (77 different farms distributed in 104 
the cantons Zürich, Zug, Graubünden, Aargau, Thurgau, St. Gallen). The isolates were 105 
collected between March 2011 and February 2012. Milk samples were collected from the 106 
affected quarter of each cow in an aseptical manner during farm calls by the attending 107 
veterinarian. Milk samples were streaked onto sheep blood agar (Oxoid, Pratteln, 108 
Switzerland), as well as onto bromothymol blue lactose cystine agar (VWR International 109 
AG, Dietikon, Switzerland) and incubated at 37°C over night. All gram-positive, catalase-110 
positive cocci forming black colonies without an opaque zone on rabbit plasma fibrinogen 111 
agar (Oxoid, Cambridge, United Kingdom) were classified as presumptive CNS. The 112 
isolates were stored at -80°C. 113 
 114 
Species Identification 115 
CNS species identification was performed by matrix-assisted laser desorption ionization-116 
time of flight mass spectrometry (MALDI-TOF MS). Briefly, one colony of a fresh 117 
overnight culture of all 120 isolates grown on sheep blood agar (Oxoid, Pratteln, 118 
Switzerland) was spotted in duplicate on a steel target plate, overlaid with 1µl 25% formic 119 
acid, air-dried and again overlaid with 1 µl matrix consisting of a saturated solution of 120 
alpha-cyano-4-hydroxycinnamic acid (Sigma-Aldrich, Buchs, Switzerland) in 33% 121 
acetonitrile (Sigma-Aldrich), 33% ethanol and supplemented with 3% trifluoroacetic acid, 122 
and air-dried within minutes at room temperature. Spectra were acquired using an AximaTM 123 
confidence (Shimadzu-Biotech Corp., Kyoto, Japan) MALDI-TOF mass spectrometer in 124 
linear positive mode at a laser frequency of 50 Hz and within a mass range from 2000-20000 125 
Da. Acceleration voltage equalled 20kV, and the extraction delay time was 200 ns. A 126 
minimum of 10 laser shots was used to generate each ion spectrum. For each bacterial 127 
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sample, a total of 50 ion spectra per spot were averaged and processed using the 128 
LaunchpadTM v.2.8 Software (Shimadzu-Biotech Corp., Kyoto, Japan). Peaks lists were 129 
imported in ASCII format into SARAMISTM (Spectral Archive And Microbial Identification 130 
System, AnagnosTec, Potsdam-Golm, Germany) for automated species identification.  131 
To confirm species identification, 23 randomly chosen strains were identified by sequencing 132 
an internal fragment of the sodA gene following a protocol of Poyart et al. (2001) with slight 133 
modifications. PCRs were performed in a T3000 thermocycler (Biometra, Goettingen, 134 
Germany) in a final volume of 50 µL containing a minimum of 150 ng of DNA, 2 µM of 135 
each primer, 200 µM of each deoxynucleoside triphosphate, 2 U of FastStart High Fidelity 136 
polymerase (Roche, Basel, Switzerland), and 1x reaction buffer containing 18 mM MgCl2. 137 
PCR mixtures underwent an initial denaturation for 3 min at 95 °C and were subsequently 138 
subjected to 30 cycles of amplification: 30 s denaturation at 95°C, 60 s annealing at 39 °C, 139 
and 45 s elongation at 72 °C. Amplicons were purified, sequenced and the results were 140 
blasted against the GenBank database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 141 
 142 
Susceptibility Testing 143 
The isolates were subjected to antimicrobial susceptibility testing using the standard disk 144 
diffusion method to classify isolates as susceptible, intermediate, or resistant depending on 145 
respective zone diameters following CLSI standard protocols (Clinical and Laboratory 146 
Standards Institute, 2008). All antimicrobial agents were chosen with regard to their 147 
relevance in mastitis therapy. Antibiotic agents tested included ampicillin (30µg), 148 
amoxicillin (20µg) with clavulanic acid (10µg), cephalothin (30µg), ceftiofur (30µg), 149 
erythromycin (15µg), cefoxitin (30µg), gentamicin 10 (µg), kanamycin (30µg), kanamycin-150 
cefalexin (30µg/15µg), penicillin (10U.I.), and penicillin-novobiocin (10U.I/30µg). Mueller-151 
Hinton agar, as well as disks containing ceftiofur and penicillin-novobiocin were provided 152 
by Oxoid, while disks containing cefalexin-kanamycin (Ubrolexin®) were provided by 153 
7 
Boehringer Ingelheim (Basel, Switzerland). All other disks containing antibiotic agents were 154 
obtained from Becton Dickinson (Basel, Switzerland). The direct colony suspension method 155 
(recommended by CLSI for CNS) was used to prepare bacterial suspension of 0.5 Mac 156 
Farland turbidity. Subsequently, bacterial suspensions were swabbed uniformly across a 157 
Müller-Hinton agar plate and filter paper disks impregnated with the respective 158 
antimicrobial agents were placed on the surface of the agar using a dispenser. Plates were 159 
incubated at 35 °C for 18 h and the zone of inhibition (in mm) was assessed and measured 160 
using a calliper. Accuracy of the test system was monitored by including the reference strain 161 
S. aureus ATCC 25923. The presence of the mecA gene was confirmed by PCR for all 162 
cefoxitin resistant strains using the primers and cycling conditions published by Mehrotra et 163 
al. (2000). 164 
 165 
Results and Discussion 166 
Using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-167 
TOF MS), the 120 strains belonged to twelve different staphylococcal subspecies - S. 168 
chromogenes (33%), S. xylosus (28%), S. sciuri (13%), S. haemolyticus (9%), S. epidermidis 169 
(4%), S. simulans (4%), S. warneri (3%), S. equorum (2%), S. hyicus (2%), S. cohnii (1%), 170 
S. succinus (1%), and S. fleuretti (1%) (Fig. 1). MALDI-TOF MS identification was 171 
confirmed by sequencing sodA in a subset of 23 isolates, proving MALDI-TOF MS to be a 172 
fast and reliable tool for species identification of CNS that is suitable for screening large 173 
numbers of samples. 174 
The antimicrobial susceptibility data generated by disk diffusion is listed in Table 1. Overall, 175 
resistance rates in CNS were high, with 39% of isolates exhibiting resistance to ampicillin 176 
and penicillin, 6% of isolates being resistant to amoxicillin with clavulanic acid, ceftiofur, 177 
cephalothin, and cefoxitin, and 5% being resistant to erythromycin. In rare cases resistance 178 
to gentamicin (2%), kanamycin (2%), and kanamycin-cefalexin (1%) was detected. The only 179 
antimicrobial agent that all CNS isolates were susceptible to was penicillin-novobiocin, 180 
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which represents the single antimicrobial agent tested in this study that has not been licenced 181 
for bovine mastitis therapy in Switzerland yet. S. sciuri and S. haemolyticus exhibited 182 
especially high rates of multiresistant strains, with one strain each being susceptible to only 183 
one of the licensed antimicrobial agents tested (S. sciuri: erythromycin,  S. haemolyticus: 184 
kanamycin-cefalexin). All S. simulans and S. hyicus isolates were susceptible to all 185 
antimicrobial agents tested. 186 
Prevalence and antimicrobial resistance rates that can be found in the literature need to be 187 
treated with caution, as most authors relied on biochemical/ phenotypic characteristics that 188 
were recently shown not to be suited for CNS species identification ( Taponen and Pyörälä, 189 
2009; De Vliegher et al., 2012). S. chromogenes, the species most frequently isolated from 190 
bovine milk samples in our study, was reported to represent the most common CNS species 191 
in bovine IMI (Taponen and Pyörälä, 2009). In contrast, we found only low numbers of S. 192 
simulans, a CNS species very frequently identified by previous studies (Jarp, 1991; Waage 193 
et al., 1999). In our study, we also detected a high rate of S. xylosus among the total number 194 
of CNS (28%). S. chromogenes, S. simulans, and S. xylosus were reported to induce a 195 
particularly strong increase in milk SCC, comparable to S. aureus (Supré et al., 2011).  196 
The antimicrobial resistance rates that we determined among CNS isolated from bovine milk 197 
samples in Switzerland resemble those of other European studies. Penicillin resistance for 198 
CNS obtained from mastitis equalled 36% in Norway, 25% in Denmark, 41-61% in the 199 
Netherlands, and 32% in Finland (Taponen and Pyörälä, 2009). We detected the mecA gene 200 
in 6% of all CNS isolates, comprising five of the 15 S. sciuri, one of the 11 S. haemolyticus, 201 
and the only isolated S. succinus strain. This is in accordance with data from Finland and the 202 
Netherlands, reporting higher prevalence of mecA in CNS compared to S. aureus (Taponen 203 
and Pyörälä, 2009). Moreover, the species distribution of strains harbouring the mecA gene 204 
fits with the data of a recently published study with a focus on methicillin resistant CNS 205 
(Huber et al., 2011).   206 
The antimicrobial resistance rates determined for different species varied greatly in our 207 
study. Thus, the common research practice of investigating CNS as a group, while omitting 208 
discrimination on a species level, seems highly questionable. MALDI-TOF MS was shown 209 
9 
to enable fast and reliable species identification of CNS, suitable for its application in the 210 
routine mastitis diagnostic.  211 
 212 
 213 
Acknowledgments   214 
The authors would like to thank Dr. Sabrina Corti for her kind support in collecting the CNS 215 
isolates. 216 
 217 
 218 
References  219 
 220 
Allaker R. P., Whitlock M., Lloyd D. H.: Cytotoxic activity of Staphylococcus hyicus. Vet. 221 
Microbiol. 1991, 26: 161-166. 222 
 223 
De Vliegher S., Fox L. K., Piepers S., McDougall S., Barkema H. W.: Mastitis in dairy 224 
heifers: nature of the disease, potential impact, prevention, and control. J. Dairy Sci. 225 
2012, 95: 1025-1040.  226 
 227 
Gillespie B. E., Headrick S. I., Boonyayatra S., Oliver, S. P.: Prevalence and persistence of 228 
coagulase-negative Staphylococcus species in three dairy research herds. Vet. 229 
Microbiol. 2009, 134: 65-72.  230 
 231 
Green L. E., Schukken Y. H., Green M. J.: On distinguishing cause and consequence: do 232 
high somatic cell counts lead to lower milk yield or does high milk yield lead to lower 233 
somatic cell count? Prev. Vet. Med. 2006, 76: 74-89.  234 
 235 
Huber H., Ziegler D., Pflüger V., Vogel G., Zweifel C., Stephan R.: Prevalence and 236 
characteristics of methicillin-resistant coagulase-negative staphylococci in livestock, 237 
food of animal origin, and humans in contact with farm animals. BMC Vet. Res. 2011, 238 
7:6. 239 
 240 
Jarp J.: Classification of coagulase-negative staphylococci isolated from bovine clinical and 241 
subclinical mastitis. Vet. Microbiol. 1991, 27: 151-158. 242 
 243 
Makovec J. A., Ruegg, P. L.: Results of milk samples submitted for microbiological 244 
examination in Wisconsin from 1994 to 2001. J. Dairy Sci. 2003, 86: 3466-3467. 245 
 246 
Mehrotra M., Wang G., Johnson W. M.: Multiplex PCR for detection of genes for 247 
Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, 248 
and methicillin resistance. J. Clin. Microbiol. 2000, 38: 1032-1035. 249 
 250 
Pate M., Zdovc I., Avberšek J., Ocepek M., Pengov A., Podpečan O.: Coagulase-negative 251 
staphylococci from non-mastitic bovine mammary gland: characterization of 252 
10 
Staphylococcus chromogenes and Staphylococcus haemolyticus by antibiotic 253 
susceptibility testing and pulsed-field gel electrophoresis. J. Dairy Res. 2012, 79: 129-254 
134.  255 
 256 
Piessens V., Van Coillie E., Verbist B., Supré K., Braem G., Van Nuffel A., De Vuyst,  L., 257 
Heyndrickx M, De Vliegher S.: Distribution of coagulase-negative Staphylococcus 258 
species from milk and environment of dairy cows differs between herds. J. Dairy Sci. 259 
2011, 94: 2933-2944.  260 
 261 
Poyart C., Quesne G., Boumaila C., Trieu-Cuot P.: Rapid and accurate species-Level 262 
identification of coagulase-negative Staphylococci by using the sodA gene as a target. 263 
J. Clin. Microbiol. 2001, 39: 4296-4301.  264 
 265 
Reyher K. K., Dohoo I. R., Scholl D. T., Keefe G. P.: Evaluation of minor pathogen 266 
intramammary infection, susceptibility parameters, and somatic cell counts on the 267 
development of new intramammary infections with major mastitis pathogens. J. Dairy 268 
Sci., 2012, 95: 3766-3780.  269 
 270 
Schukken Y. H., González R. N., Tikofsky L. L., Schulte H. F., Santisteban C. G., Welcome F. 271 
L., Bennett G. J., Zurakowski M. J., Zadoks R. N..: CNS mastitis: nothing to worry 272 
about? Vet. Microbiol. 2009, 134: 9-14.  273 
 274 
Supré K., Haesebrouck F., Zadoks R. N., Vaneechoutte M., Piepers S., De Vliegher S.: Some 275 
coagulase-negative Staphylococcus species affect udder health more than others. J. 276 
Dairy Sci. 2011, 94: 2329-2340.  277 
 278 
Taponen S., Pyörälä S.: Coagulase-negative staphylococci as cause of bovine mastitis- not 279 
so different from Staphylococcus aureus? Vet. Microbiol. 2009, 134: 29-36.  280 
 281 
Tenhagen B., Köster G., Wallmann J., Heuwieser W.: Prevalence of mastitis pathogens and 282 
their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J. 283 
Dairy Sci. 2006, 89: 2542-2551.  284 
 285 
Waage S., Mørk T., Røros A., Aasland D., Hunshamar A., Odegaard S.: Bacteria associated 286 
with clinical mastitis in dairy heifers. J. Dairy Sci. 1999, 82: 712-719. 287 
 288 
Waller K. P., Aspán A., Nyman A., Persson Y., Andersson U. G.: CNS species and 289 
antimicrobial resistance in clinical and subclinical bovine mastitis. Vet. Microbiol. 290 
2011, 152: 112-116.  291 
 292 
Zhang S., Maddox C. W.: Cytotoxic activity of coagulase-negative staphylococci in bovine 293 
mastitis. Infect. Immun. 2000, 68: 1102-1108.  294 
 295 
 296 
 297 
 298 
 299 
11 
 300 
Corresponding author: Sophia Johler, Institute for Food Safety and Hygiene, Vetsuisse 301 
Faculty University of Zurich, Winterthurerstrasse 272, 8057 Zurich, Switzerland, Phone: 302 
+41-446358651, Fax: +41-446358908, E-mail: sophia.johler@uzh.ch 303 
 304 
305 
12 
  306 
 307 
 308 
 309 
 310 
 311 
 312 
 313 
 314 
 315 
 316 
 317 
 318 
 319 
Figure 1. Species distribution of the 120 CNS strains.  320 
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Table 1.  Overview on the antimicrobial susceptibility of the 120 CNS strains tested.   332 
 333 
Species 
 
No. of 
strains 
No. of resistant strains1  
AM P AMC EFT CF FOX E GM K K/CFX P/NB 
S. chromogenes n = 40 9 9 0 0 0 0 1 0 0 0 0 
S. xylosus n = 33 20 20 0 0 0 0 (2)2 0 0 0 0 
S. sciuri n = 15 6 6 5 5 5 5 1 (1)2 1 1 1 0 
S. haemolyticus n = 11 5 5 1 1 1 1 1 1 1 0 0 
S. epidermidis n = 5 3 3 0 0 0 0 0 0 0 0 0 
S. simulans n = 5 0 0 0 0 0 0 0 0 0 0 0 
S. warneri n = 4 2 2 0 0 0 0 0 0 0 0 0 
S. equorum n = 2 0 0 0 0 0 0 2 0 0 0 0 
S. hyicus n = 2 0 0 0 0 0 0 0 0 0 0 0 
S. cohnii n = 1 0 0 0 0 0 0 1 0 0 0 0 
S. succinus n = 1 1 1 1 1 1 1 (1)2 0 0 0 0 
S. fleuretti n = 1 1 1 0 0 0 0 0 0 0 0 0 
Total 120 47 47 7 7 7 7 6 2 2 1 0 
 334 
1 Abbreviations: AM = ampicillin, P = penicillin, AMC = amoxicillin with clavulanic acid, 335 
EFT = ceftiofur, CF = cephalothin, FOX = cefoxitin, E = erythromycin, GM = gentamicin, 336 
K = kanamycin, K/CFX = kanamycin-cefalexin, P/NB = penicillin-novobiocin 337 
2 Numbers in brackets equal the percentage of strains that exhibited intermediate resistance 338 
to the antibiotic agents tested 339 
